A total of 96.84% of patients whose cell source was peripheral blood had adverse reactions; reactions were also observed in patients whose cell source was bone marrow.
En los pacientes de fuente de sangre periférica, 96,84% presentaron reacciones adversas; también fueron observadas reacciones en pacientes con fuente de médula ósea.
Nos pacientes de fonte de sangue periférico, 96,84% apresentaram reações adversas; também foram observadas reações em pacientes com fonte de medula óssea.